跳至主要内容
临床试验/CTRI/2026/01/101845
CTRI/2026/01/101845尚未招募2 期

A RANDOMIZED CONTROLLED CLINICAL TRIAL ON EFFICACY OF DARUHARIDRA GHANAWATI INTERNALLY IN THE MANAGEMENT OF HYPERLIPIDAEMIA WITH SPECIAL REFERENCE TO MEDOROGA

Dr Payal Mohan Rabbewar1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2026年2月5日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
30
试验地点
1

研究概览

简要总结

This study is Randomized open labelled controlled clinical study of Daruharidra Ghanvati (3gm total dose)

divided in 3 tab BD for 30 days and follow up on 0th,31st day.This study is

conducted as a part of PG course at single centre.The primary outcome is decrease in lipid profile value, decrease in

shariragaurava,kshudhadhikya,pipasadhikya,swedadhikya,angagandha,kshudrashwasa,decrease

in weight,BMI.

研究设计

研究类型
Interventional

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
All

入选标准

  • Patients as per diagnostic criteria
  • Patients between age group 18-45 years
  • Patients of either gender
  • Irrespective of sociological condition of patients.

排除标准

  • Patients already taking medicines for Hyperlipidemia.
  • patients having lipid levels which are out of range.
  • Patients having any other systemic disorders with complications.
  • Pregnant and lactating women.

研究者

发起方
Dr Payal Mohan Rabbewar
申办方类型
Other [Self Sponsor]
责任方
Principal Investigator
主要研究者

Dr Payal Rabbewar

Government Ayurved College , Nanded

研究点 (1)

Loading locations...

相似试验